PT Soho Global Health Tbk
PT Soho Global Health Tbk, together with its subsidiaires, operates as a healthcare company in Indonesia. It operates through Distribution, Professional Product, Consumer Health, Alliance, and Others segments. The company researches, develops, and markets specialty-focused medicines for use in the therapeutic areas of immunomodulator, respiratory, inflammation, and liver diseases; offers nonpresc… Read more
PT Soho Global Health Tbk (SOHO) - Net Assets
Latest net assets as of June 2025: Rp2.70 Trillion IDR
Based on the latest financial reports, PT Soho Global Health Tbk (SOHO) has net assets worth Rp2.70 Trillion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp5.48 Trillion) and total liabilities (Rp2.77 Trillion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp2.70 Trillion |
| % of Total Assets | 49.38% |
| Annual Growth Rate | 12.99% |
| 5-Year Change | 23.08% |
| 10-Year Change | N/A |
| Growth Volatility | 22.23 |
PT Soho Global Health Tbk - Net Assets Trend (2017–2024)
This chart illustrates how PT Soho Global Health Tbk's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PT Soho Global Health Tbk (2017–2024)
The table below shows the annual net assets of PT Soho Global Health Tbk from 2017 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp2.72 Trillion | +13.18% |
| 2023-12-31 | Rp2.40 Trillion | -1.17% |
| 2022-12-31 | Rp2.43 Trillion | +9.93% |
| 2021-12-31 | Rp2.21 Trillion | +0.10% |
| 2020-12-31 | Rp2.21 Trillion | +67.89% |
| 2019-12-31 | Rp1.31 Trillion | +9.04% |
| 2018-12-31 | Rp1.21 Trillion | +4.37% |
| 2017-12-31 | Rp1.15 Trillion | -- |
Equity Component Analysis
This analysis shows how different components contribute to PT Soho Global Health Tbk's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 323.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp844.13 Billion | 31.09% |
| Common Stock | Rp634.58 Billion | 23.37% |
| Other Comprehensive Income | Rp175.41 Billion | 6.46% |
| Other Components | Rp1.06 Trillion | 39.08% |
| Total Equity | Rp2.72 Trillion | 100.00% |
PT Soho Global Health Tbk Competitors by Market Cap
The table below lists competitors of PT Soho Global Health Tbk ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Adicon Holdings Limited
F:K0U
|
$138.53 Million |
|
Curiositystream Inc.
NASDAQ:CURI
|
$138.54 Million |
|
PIERER Mobility AG
VI:PKTM
|
$138.63 Million |
|
Shenzhen Shenbao Industrial Co Ltd
SHE:200019
|
$138.66 Million |
|
Atal SA
WAR:1AT
|
$138.50 Million |
|
JiangXi BaiSheng Intelligent Technology Co. Ltd.
SHE:301083
|
$138.49 Million |
|
Guangzhou Metro Design And Research
SHE:003013
|
$138.48 Million |
|
AutoCanada Inc
PINK:AOCIF
|
$138.46 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PT Soho Global Health Tbk's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,399,098,000,000 to 2,715,216,000,000, a change of 316,118,000,000 (13.2%).
- Net income of 462,651,000,000 contributed positively to equity growth.
- Dividend payments of 152,300,000,000 reduced retained earnings.
- Other comprehensive income increased equity by 132,684,000,000.
- Other factors decreased equity by 126,917,000,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp462.65 Billion | +17.04% |
| Dividends Paid | Rp152.30 Billion | -5.61% |
| Other Comprehensive Income | Rp132.68 Billion | +4.89% |
| Other Changes | Rp-126.92 Billion | -4.67% |
| Total Change | Rp- | 13.18% |
Book Value vs Market Value Analysis
This analysis compares PT Soho Global Health Tbk's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 9.21x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 1.22x to 9.21x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2017-12-31 | Rp1612.82 | Rp1970.00 | x |
| 2018-12-31 | Rp1683.30 | Rp1970.00 | x |
| 2019-12-31 | Rp103.41 | Rp1970.00 | x |
| 2020-12-31 | Rp173.69 | Rp1970.00 | x |
| 2021-12-31 | Rp1739.47 | Rp1970.00 | x |
| 2022-12-31 | Rp191.27 | Rp1970.00 | x |
| 2023-12-31 | Rp189.03 | Rp1970.00 | x |
| 2024-12-31 | Rp213.94 | Rp1970.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PT Soho Global Health Tbk utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.04%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.60%
- • Asset Turnover: 1.86x
- • Equity Multiplier: 1.99x
- Recent ROE (17.04%) is above the historical average (11.99%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2017 | 2.88% | 0.82% | 1.49x | 2.36x | Rp-82.16 Billion |
| 2018 | 4.10% | 1.08% | 1.64x | 2.31x | Rp-71.11 Billion |
| 2019 | 9.03% | 2.35% | 1.54x | 2.49x | Rp-12.78 Billion |
| 2020 | 7.81% | 2.79% | 1.47x | 1.90x | Rp-48.34 Billion |
| 2021 | 24.92% | 7.78% | 1.76x | 1.82x | Rp329.41 Billion |
| 2022 | 14.69% | 4.89% | 1.63x | 1.84x | Rp113.97 Billion |
| 2023 | 15.48% | 4.53% | 1.73x | 1.98x | Rp131.43 Billion |
| 2024 | 17.04% | 4.60% | 1.86x | 1.99x | Rp191.13 Billion |
Industry Comparison
This section compares PT Soho Global Health Tbk's net assets metrics with peer companies in the Medical Distribution industry.
Industry Context
- Industry: Medical Distribution
- Average net assets among peers: $1,441,384,790,295
- Average return on equity (ROE) among peers: 8.64%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PT Soho Global Health Tbk (SOHO) | Rp2.70 Trillion | 2.88% | 1.03x | $138.50 Million |
| Enseval Putra Megatrading Tbk (EPMT) | $5.13 Trillion | 10.09% | 0.45x | $31.13 Million |
| Itama Ranoraya (IRRA) | $512.31 Billion | 10.40% | 2.24x | $4.89 Million |
| Kimia Farma Persero Tbk (KAEF) | $947.76 Billion | 5.84% | 0.53x | $16.65 Million |
| PT Medela Potentia Tbk (MDLA) | $1.71 Trillion | 18.29% | 1.59x | $130.48 |
| Millennium Pharmacon International (SDPC) | $282.50 Billion | 5.99% | 5.27x | $1.76 Million |
| Dosni Roha Indonesia Tbk PT (ZBRA) | $69.73 Billion | 1.21% | 0.95x | $1.64 Million |